Related Experiment Videos
Functional imaging in relation to parkinsonian syndromes
1MRC Cyclotron Unit, Hammersmith Hospital, London, UK.
Journal of the Neurological Sciences
|March 1, 1993
Summary
Functional imaging reveals distinct patterns of brain dysfunction in various parkinsonian disorders. Techniques like PET and SPECT can detect early dopaminergic changes and network disruptions underlying motor symptoms.
Area of Science:
- Neuroscience
- Radiology
- Neurology
Background:
- Parkinsonism presents beyond Parkinson's disease, affecting basal ganglia function.
- Diverse conditions can manifest as parkinsonism, necessitating accurate diagnostic tools.
Purpose of the Study:
- To explore the utility of functional imaging in differentiating parkinsonian disorders.
- To investigate the potential of imaging in detecting early-stage neurodegeneration and understanding motor network dysfunction.
Main Methods:
- Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) were employed.
- Assessment of regional cerebral blood flow, metabolism, and neuropharmacology.
- Utilized 18F-dopa PET for evaluating dopaminergic terminal function.
Main Results:
- Functional imaging identified specific patterns of disrupted cerebral blood flow, metabolism, and neuropharmacology in different parkinsonian disorders.
- 18F-dopa PET showed potential for detecting subclinical dopaminergic terminal dysfunction.
- Imaging elucidated network alterations associated with bradykinesia and parkinsonian tremor.
Conclusions:
- Functional imaging (PET, SPECT) is valuable for characterizing diverse parkinsonian disorders.
- 18F-dopa PET may aid in early detection of at-risk individuals.
- Imaging enhances understanding of motor network function and dysfunction in parkinsonism.